A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)

NCT07483632 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Forms of Multiple Sclerosis

Interventions

DRUG: Diroximel Fumarate
DRUG: Dimethyl Fumarate
DRUG: Fingolimod
DRUG: Placebo matching DRF
DRUG: Placebo matching DMF
DRUG: Placebo matching fingolimod

Sponsor

Biogen